Markets:

Overview

News

Currencies

International

Treasuries

ImmunoGen, Inc. - Common Stock (NQ:IMGN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 9, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ImmunoGen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Eli Lilly, Livent, Super Micro Computer And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

May 03, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 01, 2023

Via Benzinga

Crude Oil Rises 2.5%; Chevron Tops Q1 Expectations ↗

April 28, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 200 points on Friday. The Dow traded up 0.60% to 34,029.17 while the NASDAQ rose 0.40% to 12,190.35. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 28, 2023

Via Benzinga

Why Shares of ImmunoGen Jumped Friday ↗

April 28, 2023

The biotech company's first-quarter report had plenty of good news.

Via The Motley Fool

Immunogen's Earnings: A Preview ↗

April 27, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Analyst Ratings for Immunogen ↗

January 23, 2023

Via Benzinga

Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 28, 2023

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.

Via Benzinga

Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday ↗

April 28, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Analyst Ratings for Immunogen ↗

December 30, 2022

Via Benzinga

6 Analysts Have This to Say About Immunogen ↗

December 30, 2022

Via Benzinga

What 6 Analyst Ratings Have To Say About Immunogen ↗

December 30, 2022

Via Benzinga

ImmunoGen Boosts Annual Guidance On Upbeat Uptake Of Newly Approved Ovarian Cancer Drug ↗

April 28, 2023

ImmunoGen Inc (NASDAQ: IMGN) shares are surging Friday morning following its impressive first-quarter performance.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 28, 2023

Via Benzinga

Earnings Scheduled For April 28, 2023 ↗

April 28, 2023

Companies Reporting Before The Bell • GrafTech International (NYSE:EAF) is likely to report quarterly loss at $0.01 per share on revenue of $123.00 million.

Via Benzinga

Looking Into Immunogen's Return On Capital Employed ↗

November 28, 2022

Via Benzinga

After FDA Approval For Ovarian Cancer Drug, ImmunoGen Becomes Top Pick For This Analyst ↗

November 16, 2022

Via Benzinga

Could This Move Make Vertex's Next Blockbuster Even Bigger? ↗

April 12, 2023

Vertex is showing it can branch out beyond its cystic fibrosis specialty.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

April 07, 2023

Via Benzinga

Why Shares of MacroGenics Jumped Thursday ↗

March 09, 2023

The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.

Via The Motley Fool

ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing ↗

March 01, 2023

Via Benzinga

What You Missed On Wall Street On Friday ↗

December 31, 2022

In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold.

Via Talk Markets

Expert Ratings for Immunogen ↗

November 16, 2022

Via Benzinga

Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday ↗

December 30, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday ↗

December 30, 2022

Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.

Via Benzinga

ImmunoGen's Newly Approved Ovarian Cancer Drug Listed As Preferred Regime ↗

December 28, 2022

The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer treatment, which include ImmunoGen Inc's (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) as a...

Via Benzinga

Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific ↗

December 17, 2022

Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company. Boston Scientific said the acquisition will build up its presence in China, and it will...

Via Talk Markets

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors ↗

December 02, 2022

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.

Via Benzinga

Why Jim Cramer Sees 'Another Bad Quarter Ahead' For Ford, And What Will Turn Things Around ↗

November 23, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vista Outdoor Inc (NYSE: VSTO) can be "bought here. I would not push it, though."

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ImmunoGen, Inc. - Common Stock (NQ:IMGN)

Headline News about ImmunoGen, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today